The impact of age of onset and duration of Type 2 diabetes on life expectancy and serious health outcomes

Background Type 2 diabetes mellitus (T2DM) is a rapidly growing global health challenge, with an alarming increase in cases among younger populations. Early-onset T2DM follows a more aggressive disease trajectory, leading to significantly higher risks of both microvascular and macrovascular complications and a substantial reduction in life expectancy. Despite its importance, the combined influence of age at diagnosis and diabetes duration on long-term outcomes remains underexplored. Methods We conducted a nationwide, retrospective matched cohort study utilizing comprehensive Swedish national registries from 1998 to 2019. The study cohort consisted of 661,118 T2DM patients and 1,929,820 matched controls. Robust Cox regression models—adjusted for key socioeconomic and clinical confounders—were employed to assess the impact of age at diagnosis and diabetes duration on life expectancy and on all-cause, cardiovascular, and non- cardiovascular mortality. Results Our findings reveal that early-onset T2DM is associated with dramatic reductions in life expectancy. Patients diagnosed between 31 and 45 years lost an average of 8.7 years relative to controls—with women losing 9.6 years and men 8.5 years. Moreover, each one-year delay in age at diagnosis was associated with a relative risk reduction of 1.8% in all-cause mortality (HR: 0.982; 95% CI, 0.981–0.982), 2.0% in cardiovascular mortality (HR: 0.980; 95% CI, 0.979–0.981), and 1.5% in non-cardiovascular mortality (HR: 0.985; 95% CI, 0.984–0.986). Conclusion This large-scale study provides compelling evidence that early-onset T2DM significantly shortens life expectancy and escalates the risk of severe complications. The data strongly support the urgent need for targeted, aggressive management strategies in younger patients to mitigate long-term adverse outcomes. These findings have profound implications for clinical practice and public health policy, emphasizing the need to tailor treatment strategies according to the age at diagnosis.